Trial Profile
The Use of Liposomal Bupivacaine in TAP Blocks for Women Undergoing Cesarean Section
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II/III
Latest Information Update: 03 Feb 2020
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- 03 Feb 2020 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 02 Jan 2020 Planned End Date changed from 31 Dec 2019 to 31 Dec 2020.
- 02 Jan 2020 Planned primary completion date changed from 31 Dec 2019 to 31 Dec 2020.